Abbott Laboratories (ABT)vsDuke Energy Corporation (DUK)
ABT
Abbott Laboratories
$91.33
-0.59%
HEALTHCARE · Cap: $158.70B
DUK
Duke Energy Corporation
$129.55
+2.40%
UTILITIES · Cap: $100.82B
Smart Verdict
WallStSmart Research — data-driven comparison
Abbott Laboratories generates 42% more annual revenue ($45.13B vs $31.79B). DUK leads profitability with a 15.6% profit margin vs 13.9%. ABT appears more attractively valued with a PEG of 1.39. DUK earns a higher WallStSmart Score of 59/100 (C).
ABT
Buy56
out of 100
Grade: C
DUK
Buy59
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-3.5%
Fair Value
$87.68
Current Price
$91.33
$3.65 premium
Margin of Safety
-64.7%
Fair Value
$78.65
Current Price
$129.55
$50.90 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Generating 2.6B in free cash flow
Large-cap with strong market position
Reasonable price relative to book value
Strong operational efficiency at 28.1%
Areas to Watch
Moderate valuation
Weak financial health signals
Earnings declined 19.7%
Elevated debt levels
Weak financial health signals
Expensive relative to growth rate
Earnings declined 2.2%
Comparative Analysis Report
WallStSmart ResearchBull Case : ABT
The strongest argument for ABT centers on Market Cap, Free Cash Flow. PEG of 1.39 suggests the stock is reasonably priced for its growth.
Bull Case : DUK
The strongest argument for DUK centers on Market Cap, Price/Book, Operating Margin. Profitability is solid with margins at 15.6% and operating margin at 28.1%.
Bear Case : ABT
The primary concerns for ABT are P/E Ratio, Piotroski F-Score, EPS Growth.
Bear Case : DUK
The primary concerns for DUK are Debt/Equity, Piotroski F-Score, PEG Ratio. Debt-to-equity of 1.75 is elevated, increasing financial risk.
Key Dynamics to Monitor
ABT profiles as a value stock while DUK is a mature play — different risk/reward profiles.
ABT carries more volatility with a beta of 0.78 — expect wider price swings.
DUK is growing revenue faster at 8.0% — sustainability is the question.
ABT generates stronger free cash flow (2.6B), providing more financial flexibility.
Bottom Line
DUK scores higher overall (59/100 vs 56/100), backed by strong 15.6% margins. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Abbott Laboratories
HEALTHCARE · MEDICAL DEVICES · USA
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
Visit Website →Duke Energy Corporation
UTILITIES · UTILITIES - REGULATED ELECTRIC · USA
Duke Energy Corporation is an American electric power and natural gas holding company headquartered in Charlotte, North Carolina.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?